drugset / Trial / NCT03602911
A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients
NaSingle-groupOpen-labelDiagnostic
Summary
This is a proof-of-concept trial to compare 18F-FDG-PET/CT with NETSPOT (68Ga-DOTA-TATE), a commercially available radiotracer packet that utilizes 68Ga to image SSTR-specific tissue.
Timeline
- Start
- 2019-02-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-FDG | Diagnostic / imaging agent | — | — |
| Subject | 68Ga-DOTATOC | Peptide | — | — |